Spots Global Cancer Trial Database for aa
Every month we try and update this database with for aa cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA | NCT01269853 | Glioblastoma Mu... Anaplastic Astr... | Bevacizumab Bevacizumab | 18 Years - | Northwell Health | |
| A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas | NCT00080054 | Glioma Glioblastoma Astrocytoma Oligodendroglio... Brain Neoplasm | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy | NCT01956799 | Myelodysplasia Myelofibrosis Aplastic Anemia | 18 Years - | Fondazione Italiana Sindromi Mielodisplastiche-ETS | ||
| Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22 | NCT01884740 | Glioblastoma Mu... Fibrillary Astr... Glioma of Brain... Anaplastic Astr... Pilomyxoid Astr... Mixed Oligodend... Brain Stem Glio... Diffuse Intrins... | SIACI of Erbitu... | 1 Year - 21 Years | Weill Medical College of Cornell University | |
| Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22 | NCT01884740 | Glioblastoma Mu... Fibrillary Astr... Glioma of Brain... Anaplastic Astr... Pilomyxoid Astr... Mixed Oligodend... Brain Stem Glio... Diffuse Intrins... | SIACI of Erbitu... | 1 Year - 21 Years | Weill Medical College of Cornell University | |
| Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas | NCT00610571 | Glioblastoma Gliosarcoma Anaplastic Astr... | Oral Topotecan ... | 18 Years - | Duke University | |
| Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children | NCT02885324 | Glioblastoma Mu... Anaplastic Astr... Malignant Brain... High Grade Glio... | Cabozantinib | 2 Years - 21 Years | Indiana University | |
| Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab) | NCT00968240 | Glioblastoma Mu... Anaplastic Astr... | Super-Selective... | 18 Years - | Northwell Health | |
| Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy | NCT01956799 | Myelodysplasia Myelofibrosis Aplastic Anemia | 18 Years - | Fondazione Italiana Sindromi Mielodisplastiche-ETS | ||
| Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas | NCT00610571 | Glioblastoma Gliosarcoma Anaplastic Astr... | Oral Topotecan ... | 18 Years - | Duke University | |
| Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer | NCT00567580 | Prostate Cancer | PBRT PLNRT AA LHRH agonist | 18 Years - | Radiation Therapy Oncology Group | |
| Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer | NCT00567580 | Prostate Cancer | PBRT PLNRT AA LHRH agonist | 18 Years - | Radiation Therapy Oncology Group | |
| Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab) | NCT00968240 | Glioblastoma Mu... Anaplastic Astr... | Super-Selective... | 18 Years - | Northwell Health | |
| Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA | NCT01180816 | Glioblastoma Mu... Anaplastic Astr... | Super-Selective... | 18 Years - | Northwell Health | |
| Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor | NCT01470794 | Glioblastoma Mu... Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... | Toca 511 vector Toca FC | 18 Years - 80 Years | Tocagen Inc. | |
| Lifestyle Intervention for High Risk Cancer Survivors | NCT01508273 | Breast Cancer | Exercise Progra... Website Exercise DVD Survey Self-Report Ass... | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor | NCT01985256 | Glioblastoma Mu... Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... | Toca 511 Toca FC | 18 Years - 80 Years | Tocagen Inc. | |
| Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma | NCT01386710 | Glioblastoma Mu... Anaplastic Astr... | Bevacizumab and... Bevacizumab and... | 18 Years - | Northwell Health | |
| Changing Over Time of Ascorbic Acid After Chemotherapy | NCT02931942 | Leukemia (Both ... Cancer of Lung Myeloma | blood withdrawn | 18 Years - | Maastricht University Medical Center | |
| Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab) | NCT00968240 | Glioblastoma Mu... Anaplastic Astr... | Super-Selective... | 18 Years - | Northwell Health | |
| A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511 | NCT04327011 | Glioblastoma Mu... Astrocytoma Gliomas, Malign... | Toca 511 vector Toca FC • Flucy... | 18 Years - | Tocagen Inc. | |
| Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme. | NCT00645385 | Glioblastoma Mu... Anaplastic Astr... Anaplastic Olig... | MRS Spectroscop... | 18 Years - 85 Years | Weill Medical College of Cornell University | |
| Changing Over Time of Ascorbic Acid After Chemotherapy | NCT02931942 | Leukemia (Both ... Cancer of Lung Myeloma | blood withdrawn | 18 Years - | Maastricht University Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
